Rite Aid Gets OK For $575M Sale Of Pharma Benefits Program

0
303

In the ever-evolving landscape of corporate transformations, Rite Aid navigates its path towards financial recovery, with MedImpact’s bid serving as the beacon of stability in uncertain times.